About
Basic Data Updated:
7 days agoBrinton Pharmaceuticals Limited, a renowned pharmaceutical company, is known for its exceptional products in the field of medicine. The company is actively involved in the manufacturing and trading of pharmaceutical, chemical, and medicinal products. These products cater to various therapeutic segments such as skinnova, ovaline, bonacare, seedlings, and neuton. BPL has established partnerships with leading manufacturing plants that have received certifications from major accreditation bodies like US FDA, UK MHRA, WHO, GMP, ANBISA - Brazil, Ukraine, Pharmacy and Poison Board of Kenya, NAFDAC Nigeria, Ministry of Health Yemen, Ministry of Health Congo, IDA Netherlands, and Spanish Agency of Medicines and Health Care Products. These partnerships ensure that BPL's products meet the highest quality standards and are safe for consumption. With its commitment to excellence and dedication to improving healthcare, Brinton Pharmaceuticals Limited continues to be a trusted name in the pharmaceutical industry.
Industry
Company Details
- Location
Pune, Maharashtra, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
CIN/LLPIN/FCRN | U24232PN2013PLC148971 |
Company No. | 148971 |
Company Classification | Public Limited Indian Non-Government Company |
Incorporation Date | 27 Sep 2013 |
Date of AGM | 28 Sep 2023 |
Date of Balance Sheet | 31 Mar 2023 |
Listing Status | Unlisted |
ROC Code | Roc Pune |
Products or Services related to Brinton Pharmaceuticals Limited
Financials of Brinton Pharmaceuticals Limited
Brinton Pharmaceuticals Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 13.33% increase. The company also saw a substantial improvement in profitability, with a 160.49% increase in profit. The company's net worth Soared by an impressive increase of 54.08%.
Corporate Structure
Unlock access to Brinton Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Brinton Pharmaceuticals Limited
Unlock and access historical data on people associated with Brinton Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (3)
RD
Rahul Darda Managing DirectorAppointment Date: 27-Sep-2013
Status: Current
CS
Chandra Singh CFOAppointment Date: 25-Oct-2019
Status: Current
NP
Neha Pandya Company SecretaryAppointment Date: 10-Apr-2024
Status: Current
Board Members(7)
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 27 Jun 2023 | ₹5.00 Cr | Open |
Others Creation Date: 09 Jun 2023 | ₹3.00 Cr | Open |
Others Creation Date: 31 Jan 2023 | ₹13.00 Cr | Open |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Brinton Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Brinton Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
Linux Laboratories Private Limited
Active 12 years 7 monthsVisalakshi Chandramouli is a mutual person
Anderson Diagnostic Services Private Limited
Active 12 years 7 monthsVisalakshi Chandramouli is a mutual person
Recent activity within the organization
Director Appointment
Sudeep Chhallani was appointed as a Director was appointed as a Director on 11 Apr 2024 & has been associated with this company since 1 month 4 days .
11 Apr 2024Director Appointment
Ronak Hemprakash Shah was appointed as a Director was appointed as a Director on 10 Apr 2024 & has been associated with this company since 1 month 5 days .
10 Apr 2024Director Appointment
Neha Amrutlal Pandya was appointed as a Company Secretary was appointed as a Company Secretary on 10 Apr 2024 & has been associated with this company since 1 month 5 days .
10 Apr 2024Annual General Meeting
Brinton Pharmaceuticals Limited last Annual general meeting of members was held on 28 Sep 2023 as per latest MCA records.
28 Sep 2023Charges
A charge with Others amounted to Rs. 5.00 cr with Charge ID 100750207 was registered on 27 Jun 2023.
27 Jun 2023
Recent News, Updates & Announcement
- India Alternatives invests 8M in Brinton Pharma.
BioSpectrum India 14 Jun 2019
- Brinton pharma in talks with VCs to raise up to Rs 150 crore.
The company is on the road to raise further capital and has hired investment bank Citadel Securities to look for investors said one of the persons with direct knowledge of the companys plans.
Economic Times 22 Feb 2018
- Brinton Pharma eyes second round of funding to finance growth.
India Business News Mumbai Nov 23 Punebased generic drugmaker Brinton Pharmaceuticals which has raised USD 4 million from Tata Capitals healthcarefocused fund i.
Times Of India 23 Nov 2017
- Brinton Pharmaceuticals raises 4 million from Tata Capital8217s healthcare fund Mint.
Investment by Tata Capitals healthcare fund will support Brinton Pharmaceuticals entry into newer areas such as paediatrics gynaecology.
mint 04 May 2017
Frequently asked questions
What is the Incorporation or founding date of Brinton Pharmaceuticals Limited?